Perceptive Advisors’s Gilead Sciences GILD Stock Holding History

Perceptive Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,500,000	Closed	-$11.2M	–	130
2020 Q1	$11.2M	Buy	+1,500,000	New	+$104M	0.29%	57
2017 Q4	–	Sell	-40,000	Closed	-$3.24M	–	140
2017 Q3	$3.24M	Buy	+40,000	New	+$3.06M	0.12%	82
2016 Q2	–	Sell	-6,024	Closed	-$553K	–	185
2016 Q1	$553K	Buy	6,024 +3,567	+145%	+$322K	0.05%	114
2015 Q4	$249K	Hold	2,457	–	–	0.02%	114
2015 Q3	$241K	Hold	2,457	–	–	0.02%	124
2015 Q2	$288K	Sell	2,457 -7,543	-75%	-$824K	0.02%	143
2015 Q1	$981K	Buy	+10,000	New	+$1.02M	0.08%	102
2014 Q2	–	Sell	-50,000	Closed	-$3.54M	–	130
2014 Q1	$3.54M	Hold	50,000	–	–	0.37%	52
2013 Q4	$3.76M	Sell	50,000 -814,070	-94%	-$56.7M	0.45%	42
2013 Q3	$54.3M	Buy	864,070 +75,710	+10%	+$4.52M	4.41%	7
2013 Q2	$40.4M	Buy	+788,360	New	+$41.1M	4.08%	7

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors's GILD Position: Q2 2020 in Review

Perceptive Advisors sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 1,500,000 shares — an estimated $11.2M sold.

Perceptive Advisors first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $54.3M in Q3 2013. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Perceptive Advisors reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Perceptive Advisors sold 1,500,000 Gilead Sciences shares in Q2 2020, an estimated $11.2M.
Perceptive Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Perceptive Advisors's Gilead Sciences position peaked at $54.3M in Q3 2013.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Perceptive Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.